Prevalence of the Academic Research Consortium high bleeding risk criteria in patients undergoing endovascular therapy for peripheral artery disease in lower extremities

Hashimoto, Ryota; Numasawa, Yohei; Yokokura, Souichi; Daigo, Kyohei; Sakata, Shingo; Imaeda, Shohei; Hitomi, Yasuhiro; Sato, Kazuki; Taruoka, Akira; Haginiwa, Sho; Kojima, Hidenori; Tanaka, Makoto; Kuno, Toshiki; Kodaira, Masaki

doi:10.1007/s00380-021-01813-2

Cited by 4 publications

(2 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Yoshioka et al reported a higher incidence of bleeding events in patients with LEAD that met the ARC-HBR criteria 5) . Similarly, at approximately the same time, Hashimoto et al showed that the patients with LEAD that met the ARC-HBR criteria showed a higher incidence of adverse events 12) . Tomoi et al also reported the usefulness of the ARC-HBR criteria for patients with LEAD after EVT up to 5 years of follow-up 6) .…”

Section: Study Limitationsmentioning

confidence: 87%

Chronic Limb-Threatening Ischemia is a Residual Bleeding Risk Factor among Patients with Lower Extremity Artery Disease

Tokuda,

Yoshioka,

Koyama

et al. 2024

JAT

View full text Add to dashboard Cite

Aim: Lower-extremity artery disease (LEAD) is a high-risk factor for bleeding. However, the specific risk factors for bleeding in patients with LEAD remain unclear. We aimed to identify risk factors for bleeding in patients with LEAD after endovascular treatment (EVT). Methods: This multicenter, retrospective, observational study included 732 consecutive patients with LEAD who underwent EVT between January 2018 and December 2019. Patient characteristics, laboratory data, target lesions, and medications were compared between patients with and without chronic limb-threatening ischemia (CLTI). Predictive bleeding risk factors were explored using Cox regression analysis with differential models. Results: In model 1, a body mass index (BMI) ＜18.5 kg/m 2 , prior heart failure, high bleeding risk, use of single antiplatelet therapy (SAPT) plus warfarin, and CLTI were predictive bleeding risk factors (hazard ratio [HR] 2.05; 95% confidence interval [CI] 1.13-3.52; p ＜0.01; HR 2.15; 95% CI 1.28-3.55; p ＜0.01; HR 3.40; 95% CI 1.28-3.55; p ＜0.01; HR 2.05; 95% CI 1.33-5.84; p ＜0.01; respectively). In model 2, a BMI ＜18.5 kg/m 2 , prior heart failure, anemia (＜11 g/dL), low platelet count (＜10*10 4 /µL), chronic kidney disease, use of single antiplatelet therapy (SAPT) plus warfarin, and CLTI were independent risk factors for bleeding (model 2: HR 2.05; 95% CI 1.12-3.56; p =0.02; HR 2.35; 95% CI 1.39–3.90; p ＜0.01; HR 2.71; 95% CI 1.64–4.50; p ＜0.01; HR 2.66; 95% CI 1.00–5.89; p =0.05; HR 2.47; 95% CI 1.25–5.45; p ＜0.01; HR 2.79; 95% CI 1.24-5.63; p =0.01; respectively) Conclusions: CLTI is a residual and predictive risk factor for bleeding in patients with LEAD. We have to pay attention to the bleeding events of patients with CLTI after EVT during follow-up.

show abstract

Section: Study Limitationsmentioning

confidence: 87%

Chronic Limb-Threatening Ischemia is a Residual Bleeding Risk Factor among Patients with Lower Extremity Artery Disease

Tokuda,

Yoshioka,

Koyama

et al. 2024

JAT

View full text Add to dashboard Cite

show abstract

“…However, Seto et al [ 1 ] reported access site complications, such as retroperitoneal hemorrhage, pseudoaneurysm, and arteriovenous fistulas. In addition, Hashimoto et al [ 2 ] reported that patients who undergo EVT have a high risk of bleeding. The transradial approach was shown to reduce the incidence of access site complications in patients who underwent percutaneous coronary interventions in a study by Ahsan et al [ 3 ].…”

Section: Introductionmentioning

confidence: 99%

Successful Endovascular Therapy Using the Transtibial Approach in a Patient With a History of Iliofemoral and Femorofemoral Surgical Bypass

Tokutake¹,

Miyauchi²,

Arikawa³

et al. 2023

Cureus

View full text Add to dashboard Cite

Multiple stenotic lesions may restrict the access sites for endovascular therapy in the lower extremity arteries. Because guide sheaths used for endovascular therapy have recently become easier to insert, they are directly inserted into the posterior tibial or dorsalis pedis artery to perform the transtibial approach. We herein describe an 81-year-old man who was admitted to our hospital because of claudication of the left lower extremity. He had a history of left iliofemoral and femorofemoral bypass surgery. The patient’s symptom was due to a stenotic lesion extending from the left common femoral artery to the distal part of the left superficial femoral artery. In an angiographic procedure using the antegrade approach via the right radial artery, a multipurpose catheter became stuck in the middle of the left iliofemoral bypass. The antegrade ipsilateral approach was too close to the stenotic lesion for the insertion of the guide sheath. Therefore, a retrograde approach using a 5-French guide sheath inserted via the dorsalis pedis artery was successfully performed.

show abstract

Two-year outcomes of endovascular therapy for femoropopliteal arterial lesions for patients with high bleeding risk

Shima,

Taninobu,

Ikuta

et al. 2024

Cardiovasc Interv and Ther

View full text Add to dashboard Cite

Prevalence of the Academic Research Consortium high bleeding risk criteria in patients undergoing endovascular therapy for peripheral artery disease in lower extremities

Cited by 4 publications

References 36 publications

Chronic Limb-Threatening Ischemia is a Residual Bleeding Risk Factor among Patients with Lower Extremity Artery Disease

Chronic Limb-Threatening Ischemia is a Residual Bleeding Risk Factor among Patients with Lower Extremity Artery Disease

Successful Endovascular Therapy Using the Transtibial Approach in a Patient With a History of Iliofemoral and Femorofemoral Surgical Bypass

Two-year outcomes of endovascular therapy for femoropopliteal arterial lesions for patients with high bleeding risk

Contact Info

Product

Resources

About